{
    "eid": "2-s2.0-85072234742",
    "title": "Rhinacanthin-C mediated herb-drug interactions with drugtransporters and phase i drug-metabolizing enzymes",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [],
    "authors": [
        "Wilasinee Dunkoksung",
        "Nontima Vardhanabhuti",
        "Pongpun Siripong",
        "Suree Jianmongkol"
    ],
    "citedby-count": 9,
    "ref-count": 56,
    "ref-list": [
        "Gemfibrozil greatly increases plasma concentrations of cerivastatin",
        "Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3",
        "CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide",
        "Herb-drug interactions: Challenges and opportunities for improved predictions",
        "Drug interactions with statins",
        "Rhinacanthin-C enhances doxorubicin cytotox-icity via inhibiting the functions of P-glycoprotein and MRP2 in breast cancer cells",
        "Assessment of the time-dependent inhibition (TDI) potential of test compounds with human liver microsomes by IC50 shift method using a nondilution approach",
        "Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS",
        "Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier",
        "Solitary inhibition of the breast cancer resistance protein efflux transporter results in a clinically significant drug-drug interaction with rosuvastatin by causing up to a 2-fold increase in statin exposure",
        "Membrane transporters in drug development",
        "Antiproliferative activity of Rhinacanthus nasutus (L.) Kurz extracts and the active moiety",
        "In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes",
        "Role of transporters in drug interactions",
        "In vitro inhibitory mechanisms and molecular docking of 19-S-19-acetoxychavicol acetate on human cytochrome P450 enzymes",
        "The mechanism of the interaction between amiodarone and warfarin in humans",
        "P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel",
        "Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines",
        "New biological activities of Rhinacanthins from the root of Rhinacanthus nasutus",
        "Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin",
        "Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers",
        "Drug-drug interactions: Designing development programs and appropriate product labeling",
        "Critical differences between enzyme sources in sensitivity to detect time-dependent inactivation of CYP2C8",
        "Impact of OATP transporters on pharmacokinetics",
        "Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake",
        "Characterization of ursodeoxycholic and norursodeoxycholic acid as substrates of the hepatic uptake transporters OATP1B1, OATP1B3, OATP2B1 and NTCP",
        "Transporters and drug-drug interactions: Important determinants of drug disposition and effects",
        "Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918",
        "High-throughput cytochrome P450 cocktail inhibition assay for assessing drug-drug and drug-botanical interactions",
        "Warfarin-amiodarone drug-drug interactions: Determination of [I] u)/K(I,u) for amiodarone and its plasma metabolites",
        "Cytochrome P4502C9: An enzyme of major importance in human drug metabolism",
        "Clinical relevance of drug efflux pumps in the gut",
        "Impact of drug transporter studies on drug discovery and development",
        "Metabolizing enzymes and drug-drug interactions in drug discovery and development",
        "Pharmacokinetic herb-drug interactions: Insight into mechanisms and consequences",
        "The human intestinal cytochrome P450 \"pie\"",
        "RP-HPLC analysis of rhinacanthins in Rhinacanthus nasutus: Validation and application for the preparation of rhi-nacanthin high-yielding extract",
        "Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier",
        "Mechanism-based inactivation of cytochrome P450 2A6 and 2A13 by Rhinacanthus nasutus constituents",
        "Clinical pharmacokinetics of fluvastatin",
        "The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3",
        "Two new naphthoquinones with antiviral activity from Rhinacanthus nasutus",
        "Antidiabetic naphthoquinones and their plant resources in Thailand",
        "Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: Analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil",
        "Antiproliferative naphthoquinone esters from Rhinacanthus nasutus Kurz. roots on various cancer cells",
        "Induction of apoptosis in tumor cells by three naphthoquinone esters isolated from Thai medicinal plant: Rhinacanthus nasutus KURZ",
        "Pharmacokinetic interactions between drugs and botanical dietary supplements",
        "Cytochrome P450 2C9-CYP2C9",
        "Predicting in vivo drug interactions from in vitro drug discovery data",
        "Effects of rhinacanthin-C on function and expression of drug efflux transporters in Caco-2 cells",
        "Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb-drug interactions",
        "An update on the role of intestinal cytochrome P450 enzymes in drug disposition",
        "A regulatory viewpoint on transporter-based drug interactions",
        "Identification of drugs that interact with herbs in drug development"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60029487",
            "affilname": "National Cancer Institute Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029487",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}